Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/23904Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bazban-Shotorbani, S | - |
| dc.contributor.author | Gavins, F | - |
| dc.contributor.author | Kant, K | - |
| dc.contributor.author | Dufva, M | - |
| dc.contributor.author | Kamaly, N | - |
| dc.date.accessioned | 2022-01-08T10:09:29Z | - |
| dc.date.available | 2022-01-08T10:09:29Z | - |
| dc.date.issued | 2022-01-05 | - |
| dc.identifier | 202270011 | - |
| dc.identifier.citation | Bazban-Shotorbani, S., Gavins, F., Kant, K., Dufva, M. and Kamaly, N. (2022) 'A Biomicrofluidic Screening Platform for Dysfunctional Endothelium-Targeted Nanoparticles and Therapeutics', Advanced NanoBiomed Research, 2, 2270011, pp. 1-1 [cover picture]. doi: 10.1002/anbr.202270011. | en_US |
| dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/23904 | - |
| dc.description.abstract | Copyright © 2022 The Author(s) and Wiley-VCH GmbH. Biomicrofluidic Models Biomicrofluidic models allow nanoparticle-cellular interactions to be studied under physiological flow conditions. Investigating nanoparticle biophysicochemical properties in models that resemble disease can provide valuable information about the nano-bio interface. By screening nanoparticles dynamically against a developed dysfunctional-endothelium-on chip model, Nazila Kamaly and co-workers show in article number 2100092 that nanoparticle size is a dominant factor beyond targeting ligands. Furthermore, tight junction disruption can be restored by the inflammation resolving mediator Annexin A1. | en_US |
| dc.description.uri | https://onlinelibrary.wiley.com/doi/10.1002/anbr.202270011 | - |
| dc.format | Cover picture | - |
| dc.format.medium | Electronic | - |
| dc.language.iso | en_US | en_US |
| dc.publisher | Wiley-VCH GmbH | en_US |
| dc.rights | © 2022 Wiley-VCH GmbH [and the Author(s)]. This is an open access article [cover picture and abstract] under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | - |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
| dc.title | A Biomicrofluidic Screening Platform for Dysfunctional Endothelium-Targeted Nanoparticles and Therapeutics | en_US |
| dc.type | Image | en_US |
| dc.identifier.doi | https://doi.org/10.1002/anbr.202270011 | - |
| dc.identifier.eissn | 2699-9307 | - |
| Appears in Collections: | Dept of Life Sciences Research Papers | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Cover-Picturel.pdf | 26.97 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
